Download PDF
CC BY 4.0 · Journal of Coloproctology 2024; 44(03): e151-e155
DOI: 10.1055/s-0044-1789195
Original Article

Clinical Profile of Patients with Inflammatory Bowel Diseases in a Private Service

Gilmara Pandolfo Zabot 
1   Coloprocto Digestive System Clinic, Canoas, RS, Brazil
,
Maria Gabriela Perera 
2   University Feevale, Brazil
,
Cíntia Ribeiro Pinheiro 
2   University Feevale, Brazil
,
Éveny Moraes Prola 
2   University Feevale, Brazil
,
Sofia Costa Müller 
2   University Feevale, Brazil
,
Paulo Cezar Muxfeldt Ferreira 
2   University Feevale, Brazil
,
Ornella Sari Cassol 
3   Passo Fundo Clinical Hospital, RS, Brazil
› Author Affiliations
› Further Information
Also available at
   Permissions and Reprints

Abstract

Inflammatory bowel diseases (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), are chronic inflammatory conditions affecting the digestive tract. This study examines 188 IBD patients in a private healthcare service in Canoas/RS, Brazil, aiming to understand their clinical profiles.

Most patients were young adults, primarily white, with more women affected. Both CD and UC patients commonly experienced diarrhea, but blood in stools was more prevalent in UC. CD mostly affected the small intestine, while UC involved the rectum or extended through the colon. The diagnosis was prompt, with most CD cases diagnosed within six months and UC cases within twelve months of symptom onset. Family histories of IBD and colorectal cancer were observed, particularly in CD patients. Extraintestinal manifestations were more frequent in CD. Elevated CRP levels were common in CD, while FC values were elevated in both groups. Treatment approaches differed, with 5-ASA primarily used in UC and immunomodulators in CD. Biological therapy was less commonly employed initially.

This study aligns with global IBD trends in demographics, symptoms, and disease locations. Early diagnosis likely results from specialized private healthcare, emphasizing the importance of timely diagnosis and tailored treatment.

Keywords

Inflammatory bowel disease - Crohn's disease - Ulcerative colitis - epidemiology - incidence - prevalence - surgery


Publication History

Received: 08 October 2023

Accepted: 09 April 2024

Article published online:
04 September 2024

© 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

 

  • References

  • 1 Feuerstein JD, Isaacs KL, Schneider Y, Siddique SM, Falck-Ytter Y, Singh S. AGA Institute Clinical Guidelines Committee. AGA clinical practice guidelines on the management of moderate to severe ulcerative colitis. Gastroenterology 2020; 158 (05) 1450-1461
    CrossrefPubMedSearch in Google Scholar
  • 2 Imbrizi M, Baima JP, Azevedo MFC. et al. Second brazilian consensus on the management of crohn's disease in adults: a consensus of the brazilian organization for crohn's disease and colitis (gediib). Arq Gastroenterol 2023; 59 (Suppl. 01) 20-50
    CrossrefPubMedSearch in Google Scholar
  • 3 Baima JP, Imbrizi M, Andrade AR. et al. Second brazilian consensus on the management of ulcerative colitis in adults: a consensus of the brazilian organization for crohn's disease and colitis (gediib). Arq Gastroenterol 2023; 59 (Suppl. 01) 51-84
    CrossrefPubMedSearch in Google Scholar
  • 4 Cassol OS, Zabot GP, Saad-Hossne R, Padoin A. Epidemiology of inflammatory bowel diseases in the state of Rio Grande do Sul, Brazil. World J Gastroenterol 2022; 28 (30) 4174-4181
    CrossrefPubMedSearch in Google Scholar
  • 5 Raine T, Bonovas S, Burisch J. et al. ECCO guidelines on therapeutics in ulcerative colitis: medical treatment. J Crohn's Colitis 2022; 16 (01) 2-17
    CrossrefPubMedSearch in Google Scholar
  • 6 Zabot GP, Cassol OS, Quaresma AB. et al. Surgical management of adult crohn's disease and ulcerative colitis patients: a consensus from the brazilian organization of crohn's disease and colitis (gediib). Arq Gastroenterol 2023; 59 (Suppl. 01) 1-19
    CrossrefPubMedSearch in Google Scholar
  • 7 Quaresma AB, Damiao AOMC, Coy CSR. et al. Temporal trends in the epidemiology of inflammatory bowel diseases in the public healthcare system in Brazil: A large population-based study. Lancet Reg Health Am 2022; 13: 100298
    CrossrefPubMedSearch in Google Scholar
  • 8 Kobayashi T, Siegmund B, Le Berre C. et al. Ulcerative colitis. Nat Rev Dis Primers 2020; 6 (01) 74
    CrossrefPubMedSearch in Google Scholar
  • 9 Gasparini RG, Sassaki LY, Saad-Hossne R. Inflammatory bowel disease epidemiology in São Paulo State, Brazil. Clin Exp Gastroenterol 2018; 11: 423-429
    CrossrefPubMedSearch in Google Scholar
  • 10 Cantoro L, Di Sabatino A, Papi C. et al. The time course of diagnostic delay in inflammatory bowel disease over the last sixty years: an italian multicentre study. J Crohn's Colitis 2017; 11 (08) 975-980
    CrossrefPubMedSearch in Google Scholar
  • 11 Jayasooriya N, Baillie S, Blackwell J. et al; POP-IBD study group. Systematic review with meta-analysis: Time to diagnosis and the impact of delayed diagnosis on clinical outcomes in inflammatory bowel disease. Aliment Pharmacol Ther 2023; 57 (06) 635-652
    CrossrefPubMedSearch in Google Scholar
  • 12 Barreiro-de Acosta M, Molero A, Artime E. et al. Epidemiological, Clinical, Patient-Reported and Economic Burden of Inflammatory Bowel Disease (Ulcerative colitis and Crohn's disease) in Spain: A Systematic Review. Adv Ther 2023; 40 (05) 1975-2014
    CrossrefPubMedSearch in Google Scholar
  • 13 Mosli MH, Zou G, Garg SK. et al. C-Reactive Protein, Fecal Calprotectin, and Stool Lactoferrin for Detection of Endoscopic Activity in Symptomatic Inflammatory Bowel Disease Patients: A Systematic Review and Meta-Analysis. Am J Gastroenterol 2015; 110 (06) 802-819, quiz 820
    CrossrefPubMedSearch in Google Scholar
  • 14 Childers RE, Eluri S, Vazquez C, Weise RM, Bayless TM, Hutfless S. Family history of inflammatory bowel disease among patients with ulcerative colitis: a systematic review and meta-analysis. J Crohn's Colitis 2014; 8 (11) 1480-1497
    CrossrefPubMedSearch in Google Scholar
  • 15 Ruban M, Slavick A, Amir A. et al. Increasing rate of a positive family history of inflammatory bowel disease (IBD) in pediatric IBD patients. Eur J Pediatr 2022; 181 (02) 745-751
    CrossrefPubMedSearch in Google Scholar
  • 16 Askling J, Dickman PW, Karlén P. et al. Colorectal cancer rates among first-degree relatives of patients with inflammatory bowel disease: a population-based cohort study. Lancet 2001; 357 (9252): 262-266
    CrossrefPubMedSearch in Google Scholar
  • 17 Triantafillidis JK, Nasioulas G, Kosmidis PA. Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies. Anticancer Res 2009; 29 (07) 2727-2737
    PubMedSearch in Google Scholar
  • 18 Vavricka SR, Schoepfer A, Scharl M, Lakatos PL, Navarini A, Rogler G. Extraintestinal manifestations of inflammatory bowel disease. Inflamm Bowel Dis 2015; 21 (08) 1982-1992
    CrossrefPubMedSearch in Google Scholar